Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The Institute of Cancer Research believes that animal research is essential to understand how cancers develop within a whole organism, and how to treat it.

The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

Biovica signed an agreement with US Biotech company in clinical phase Biovica received a significant order for TKa testing services Biovica published the outcome of exercise of warrants from series ...

Among patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer, treatment with imlunestrant did not significantly improve progression-free survival (PFS) compared with ...

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Avril Mathie - who has clocked up a record of 8-1-1 since switching to the fight game after winning the Miss Swimsuit USA crown - believes the cosmetic procedure will pay off in the ring.

SamanTree Medical, a leader in oncologic surgical imaging innovation, today announced promising results from the SHIELD study ...

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.

The 38-year-old actress - who started out as a child on 'The Cosby Show' and then found worldwide fame when she took on the title role of the Disney Channel sitcom 'That's So Raven' - revealed that ...